SCHEMBL19214320

SCHEMBL19214320

Cc1ccc(N2CCNC[C@H]2C(C)C)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.43
TLR8 Q9NR97 1/20 0.43
TLR7 Q9NYK1 1/20 0.43
BPTF Q12830 1/20 0.40
HRH3 Q9Y5N1 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
HTR2C P28335 8/20 0.36
HTR2A P28223 7/20 0.36
HTR2B P41595 7/20 0.36
OGA O60502 1/20 0.34
PANK3 Q9H999 1/20 0.34
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17519369 0.82 NR1H2 (0.49) HRH3HTR2CHTR2AHTR2BOGA
Hydrochloric Acid SCHEMBL27839061 0.79 BPTF (0.41) BPTFHRH3GRIN2DGRIN3BGRIN1
SCHEMBL15542777 0.75 HTR3A (0.45) TLR9TLR8TLR7
SCHEMBL6798958 0.75 PANK3 (0.36) TLR9TLR8TLR7GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL4003712 0.75 IKBKB (0.38)
SCHEMBL19214346 0.71 NR1H2 (0.37) TLR9TLR8TLR7HTR2CHTR2A
SCHEMBL38664196 0.71 ADRB2 (0.46) TLR9TLR8TLR7HTR2CHTR2A
SCHEMBL27619754 0.71 TLR9 (0.37) TLR9TLR8TLR7HTR2CHTR2A
SCHEMBL82373 0.71 BPTF (0.64) BPTFHRH3GRIN2DGRIN3BGRIN1
SCHEMBL29902963 0.71 BPTF (0.64) BPTFHRH3GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170226067-A1 PIPERAZINE DERIVATIVES AS LIVER X RECEPTOR MODULATORS VITAE PHARMACEUTICALS, INC. (US) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226067-A1 PIPERAZINE DERIVATIVES AS LIVER X RECEPTOR MODULATORS NR1H2, NR1H3, NR1I2 TLR9 1455/4885TLR8 1336/4885TLR7 641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.